BitMine Buys 61K ETH as Calls Bottom Signals Resilience
BitMine announces a sizable addition to its Ethereum stash, buying about 61,000 ETH and boosting holdings to about 4....
Which Index Funds To Hold In Retirement 2024
Understand which index funds to hold in retirement 2024, with practical tips on allocation, rebalancing, and long-term performance.
24,968 articlesPayoneer (PAYO) 2026 Earnings: Outlook & Analysis
Payoneer’s quarterly results can illuminate how cross-border payments and freelance earnings ecosystems are evolving....
Amzy Caps Amazon’s Upside, While Capturing Income
AMZY, the YieldMax AMZN Option Income Strategy ETF, uses a synthetic covered-call approach to generate monthly distri...
Anthropic IPO Sparks Stocks Poised to Make Billions Rally
Anthropic's public listing signals a new wave of AI investment. This piece highlights which major tech names could ri...
Simple Reason NuScale Power Stock: Buy Now for Gains
NuScale Power offers a fresh path in nuclear energy with small modular reactors. This article uncovers the simple rea...
This Bond Fund That Bets on Higher Rates Draws Buyers
A niche bond ETF focused on mid-tier CLO tranches is drawing buyers as rate expectations stay elevated. The fund aims...
Leading Claude Predicts Price Surge for XRP, SOL, ADA by 2026
Claude AI projects a multi-year rally for XRP, SOL, and ADA, with end-2026 targets that would mark fresh highs amid i...
These Weapons Gave Militaries a Long-Lasting Edge in Wars
A concise look at the weapons that altered modern warfare and how investors are pricing defense tech in 2026.
This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Quantum Stock Infleqtion Shot: Why It Jumped 41% This Week
A dramatic 41% weekly jump has investors buzzing about Infleqtion. Learn what fueled the move, how to evaluate quantu...
XRP Price Analysis: Will Inflows Stall as Price Near $1?
XRP is testing the $1 threshold as ETF inflows stall after a weeks-long surge. This price analysis evaluates implicat...
Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status